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The capacity of fully grown oocytes to regulate their own microenvironment by paracrine factors secreted by the oocyte (oocyte-secreted
factors, OSFs) may in turn contribute to oocyte developmental competence. Here, we investigated if OSFs have a direct influence on oocyte
developmental competence during in vitro maturation (IVM). Bovine cumulus–oocyte complexes (COCs) were aspirated from abattoir-derived
ovaries and matured in serum-free medium. COCs were either co-cultured with denuded oocytes (DOs) or treated with specific OSFs: recombinant
bone morphogenetic protein 15 (BMP15) and/or growth differentiation factor 9 (GDF9). Following maturation, embryos were fertilized and
cultured in vitro and blastocyst development and cell number were assessed on day 8. Co-culturing intact COCs with DOs did not affect cleavage
rate, but increased (P<0.001) the proportion of cleaved embryos that reached the blastocyst stage post-insemination from 39% to 51%. OSFs also
altered blastocyst cell allocation as co-culture of COCs with DOs significantly increased total and trophectoderm cell numbers, compared to
control COCs. BMP15 alone, GDF9 alone or the two combined all (P<0.05) increased the proportion of oocytes that reached the blastocyst stage
post-insemination from 41% (controls) to 58%, 50% and 55%, respectively. These results were further verified in neutralization experiments of the
exogenous growth factors and of the native OSFs. Follistatin and the kinase inhibitor SB-431542, which antagonize BMP15 and GDF9,
respectively, neutralized the stimulatory effects of the exogenous growth factors and impaired the developmental competence of control COCs.
These results demonstrate that OSFs, and particularly BMP15 and GDF9, enhance oocyte developmental competence and provide evidence that
OSF regulation of the COC microenvironment is an important determinant of oocyte developmental programming.
© 2006 Elsevier Inc. All rights reserved.Keywords: Oocyte-secreted factors; Bone morphogenetic proteins; Growth differentiation factors; Cumulus–oocyte complex; Oocyte developmental competenceIntroduction
The capacity of a mature oocyte to support the very earliest
stages of life, fertilization, preimplantation embryo development
and implantation, is termed oocyte developmental competence
and is a measure of intrinsic oocyte quality. Oocytes gradually
and sequentially acquire developmental competence during the
course of folliculogenesis as the oocyte grows and its companion
somatic cells differentiate (Eppig et al., 1994). Many factors
during follicular development affect oocyte competence, for
example, (1) the origin of the oocyte, where oocytes derived
from large follicles are more competent than those derived from
small follicles (Lonergan et al., 1994), (2) follicle health, where
follicle dominance and atresia are associated with develop-
mental competence (Blondin and Sirard, 1995; Hagemann,⁎ Corresponding author. Fax: +61 8 82227521.
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doi:10.1016/j.ydbio.2006.06.0261999), (3) hormonal stimulation of follicle development clearly
improves oocyte competence (Sirard et al., 2006) and (4)
communication between the oocyte and its surrounding cumulus
cells (CCs) is necessary for the development of a competent
oocyte (Krisher, 2004). Importantly, oocytes matured in vitro
have a lower developmental competence compared to in vivo
matured oocytes, in part due to inadequacies of in vitro
environments to support complete oocyte maturation (Greve et
al., 1987; Rizos et al., 2002; Sutton et al., 2003).
Oocytes and their companion somatic CCs maintain a close
association from the earliest stages of follicular development,
and this coupling is necessary to maintain oocyte health and CC
development (Buccione et al., 1990a). Furthermore, the oocyte
is dependent on CCs to provide nutrients and regulatory signals
which are necessary to promote oocyte nuclear and cytoplasmic
maturation and hence the acquisition of developmental
competence (Chian and Sirard, 1995; Ka et al., 1997). Removal
of CCs at the beginning of oocyte in vitro maturation (IVM) or
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maturation, fertilization and subsequent development (Fatehi et
al., 2002; Fukui and Sakuma, 1980; Zhang et al., 1995).
As follicles grow and the antrum is formed, the oocyte and its
secreted paracrine growth factors play a crucial role in
regulating granulosa cell differentiation, separating them into
two distinct sub-types, CCs and mural granulosa cells, which
become phenotypically and functionally distinct from each
other (Eppig et al., 1997; Li et al., 2000). It is now widely
recognized that oocyte-secreted factors (OSFs) direct the
functions of their surrounding CCs, including promotion of
cell growth and prevention of death and prevention of
luteinization by regulating steriodogenesis and inhibin synthesis
and suppressing luteinizing hormone receptor expression
(Eppig, 2001; Gilchrist et al., 2004a; Hussein et al., 2005).
The identities of the OSFs that regulate granulosa and CC
functions are still emerging, however, so far, it seems clear that
growth differentiation factor 9 (GDF9) and bone morphogenetic
protein 15 (BMP15, also referred to as GDF9B) are crucial
oocyte-derived growth factors, as evidenced by the reproductive
defects in animals with mutations in these genes (reviewed in
McNatty et al., 2004) and by the ability of recombinant forms of
these growth factors to mimic the actions of the oocyte on
granulosa cells and CCs in vitro (reviewed in Gilchrist et al.,
2004a). GDF9 and BMP15 belong to the transforming growth
factor-β (TGF-β) superfamily, which has two divergent
intracellular signaling pathways: the BMP pathway utilizing
SMAD 1/5/8 messengers and the TGFβ/activin pathway using
SMADs 2 and 3. GDF9 utilizes an unusual combination of
receptors and elicits a TGF-β-like intracellular response by
activating SMAD 2/3 molecules, whereas BMP15 activates the
alternate SMAD 1/5/8 pathway (reviewed by Shimasaki et al.,
2004).
Oocytes induce expression of genes in CCs that have been
associated with oocyte maturation and subsequent embryo
developmental potential. For example, GDF9 upregulates CC
gene expression of hyaluronic acid synthase 2 (HAS2),
cyclooxygenase 2 (COX2; PTGS2) and gremlin (GREM1)
(Elvin et al., 1999; Pangas et al., 2004). OSFs play crucial roles
in processes of cumulus expansion and in mice GDF9 as well as
other OSFs are involved (Buccione et al., 1990b; Dragovic
et al., 2005). Oocytes are responsible for maintaining CCs in a
non-luteinized state, promoting growth and limiting steroid
production (Li et al., 2000). We have recently shown that OSFs
(especially BMP15) prevent CC apoptosis by maintaining a
localized gradient of anti-apoptotic factors within the COC
(Hussein et al., 2005). Furthermore, OSFs including GDF9
regulate CC amino acid and energy substrate uptake and
transport to the oocyte (Sugiura and Eppig, 2005).
The above findings support the concept that, via the secretion
of OSFs, the oocyte actively promotes the CC phenotype,
thereby maintaining a highly specialized microenvironment
immediately surrounding itself. We hypothesized that the
capacity of oocytes to secrete these factors and hence regulate
COC activity is a function of high quality oocytes and is a
determinant of oocyte developmental competence, and, as such,
oocytes compromised by IVM would benefit from exposure toadditional OSFs. The aim of this study was to determine if OSFs
enhance oocyte developmental competence during IVM.
Materials and methods
Collection of oocytes and culture conditions
Unless otherwise specified, all chemicals and reagents were purchased from
Sigma (St. Louis, MO). Bovine ovaries were collected from local abattoirs and
transported to the laboratory in warm saline (30–35°C). COCs were aspirated
from antral follicles (3 to 8 mm diameter) using an 18-gauge needle and a 10-ml
syringe containing ∼2 ml aspiration medium (HEPES-buffered Tissue Cultured
Medium-199; TCM-199, ICN Biochemicals, Irvine, CA, USA) supplemented
with 50 μg/ml kanamycin, 0.5 mM sodium pyruvate, 50 μg/ml heparin and
4 mg/ml fatty-acid-free bovine serum albumin (FAF-BSA; ICPbio Ltd,
Aukland, NZ). Intact COCs with compact cumulus vestments >∼5 cell layers
and evenly pigmented cytoplasm were selected under a dissecting microscope
and washed twice in HEPES-buffered TCM-199 and once in HEPES-buffered
TCM-199 supplemented with 10% fetal calf serum (FCS) (Invitrogen, Carlsbad,
CA). The basic medium for oocyte maturation was Bovine VitroMat (Cook
Australia, Eight Mile Plains, Qld, Australia), a medium based on the ionic
composition of bovine follicular fluid (Sutton-McDowall et al., 2005). All IVM
treatments were supplemented with 0.1 IU/ml FSH (Puregon, Organon, Oss,
Netherlands). Complexes were cultured in pre-equilibrated 300 μl drops
overlaid with mineral oil and incubated at 39°C with 5% CO2 in humidified air
for 24 h.
Treatment of cumulus–oocyte complexes
Generation of denuded oocytes
Denuded oocytes (DO) were generated by removing CCs from COCs by
vortexing for ∼4 min in 2 ml HEPES-buffered TCM-199. Any remaining CCs
were removed by repeated passage of the oocytes through a fine-bore fire-
polished glass pipette in HEPES-buffered TCM-199.
Growth factors and antagonists
Recombinant mouse GDF9 and recombinant ovine BMP15 were produced
and partially purified in-house as previously described (Gilchrist et al., 2004b;
Hickey et al., 2005; Hussein et al., 2005) using transfected 293 human
embryonic kidney cell lines (293H) originally donated by O. Ritvos (University
of Helsinki). Control conditioned medium (hereafter designated ‘293H’) was
produced from untransfected 293H cells and subjected to the same
chromatography procedures as GDF9 and BMP15 conditioned media, as
described (Hickey et al., 2005).
SB-431542, generously donated by GlaxoSmithKline (Stevenage, UK), acts
as competitive ATP binding site kinase inhibitor, specifically antagonizing the
activities of activin-receptor-like kinases (ALKs) 4, 5 and 7, without affecting
the activities of ALKs 1, 2, 3 or 6 or other cellular kinases (Inman et al., 2002).
Consequently, SB-431542 potently antagonizes the ALK 4/5 ligands: TGF-β1,
the activins and GDF9, without affecting BMP signaling (Inman et al., 2002;
Gilchrist et al., in press). We have recently demonstrated that SB-431542
completely antagonizes the growth-promoting actions of native OSFs and GDF9
on granulosa cells (Gilchrist et al., in press). Follistatin-288 was generously
donated by S. Shimasaki (University of California San Diego, USA), and we
have previously shown that this binding protein antagonizes the bioactivities of
native OSFs and recombinant BMP15 in CCs (Hussein et al., 2005).
In vitro fertilization and embryo culture
In vitro production of embryos was undertaken using defined, serum-free
media (Bovine Vitro series of media, Cook Australia). Frozen semen from a
single bull of proven fertility was used in all experiments. Briefly, thawed semen
was layered over a discontinuous (45%: 90%) Percoll gradient (Amersham
Bioscience) and centrifuged (RT) for 20–25min at 700×g. The supernatant was
removed, and the sperm pellet was washed with 500 μl Bovine VitroWash (Cook
Australia) and centrifuged for a further 5 min at 200×g. Spermatozoa were
Fig. 1. Diagrammatic illustration of the experimental design to expose COCs to
oocyte-secreted factors (OSFs) during IVM. COCs were cultured either alone or
co-cultured with denuded oocytes (COC+DOs) at a concentration of 0.5 DO/μl
for the duration of IVM. Oocytes were subsequently fertilized, and embryo
development was used to assess oocyte developmental competence.
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the fertilization media drops (Bovine VitroFert, supplemented with 0.01 mM
heparin, 0.2 mM penicillamine and 0.1 mM hypotaurine) at a final concentration
of 1×106 spermatozoa/ml. COCs were inseminated at a density of 10 μl of IVF
medium per COC for 24 h at 39°C in 6% CO2 in humidified air.
CCs were removed by gentle pipetting 23–24 h post-insemination, and five
presumptive zygotes were transferred into 20 μl drops of pre-equilibrated Cook
Bovine VitroCleave medium (Cook Australia) and cultured under mineral oil at
38.5°C in 7% O2, 6% CO2 and balance N2 for 5 days (day 1 to day 5).
On day 5, embryos were transferred in groups of 5–6 to 20 μl drops of pre-
equilibrated Bovine VitroBlast (Cook Australia) at 38.5°C overlaid with mineral
oil and cultured to day 8. Embryos were assessed for quality at day 8 according
to the definitions presented in the Manual of the International Embryo Transfer
Society (Stingfellow and Seidel, 1998) and were performed independently and
blinded by an experienced bovine embryologist.
Differential staining
Cell counts were performed using a modified version of the technique
described by Fouladi-Nashta et al. (2005). Briefly, expanded/hatched blastocysts
were placed into acid Tyrode's solution to remove the zona followed by a brief
wash in 4 mg ml−1 poly-vinyl alcohol (PVA) in phosphate-buffered saline (PBS/
PVA). Zona-free embryos were then incubated in 10 mM trinitrobenzene
sulfonic acid (TNBS) in PBS/PVA at 4°C for 10 min. Following this, embryos
were subsequently incubated with 0.1 mg ml−1 anti-dinitrophenol–BSA
antibody (Molecular Probes, Eugene, OR, USA) at 37°C for 10 min. Following
complement-mediated lysis using guinea-pig complement, embryos were
washed and incubated in 10 μg ml−1 propidium iodide for 20 min at 37°C (to
stain the trophectoderm) followed by 4 μg ml−1 bisbenzimide (Hoechst 33342;
Sigma-Aldrich) in 100% ethanol at 4°C overnight (to stain both the inner cell
mass (ICM) and trophectoderm). Embryos were then whole mounted in a drop
of 80% glycerol in PBS on microscope slides, and coverslips were sealed with
nail polish. Embryos were then examined under a fluorescence microscope
(Olympus, Tokyo, Japan) at 400× equipped with an ultraviolet filter and a digital
camera attached to determine total and compartment cell counts where inner cell
mass (ICM) nuclei appeared blue and trophectoderm (TE) nuclei stained pink.
Experimental design
Experiment 1: effect of co-culture of intact COCs with DOs during IVM on
subsequent developmental competence
To determine the effect of native OSFs on oocyte developmental
competence, COCs were randomly allocated into 2 treatment groups during
IVM: treatment (1), 30 COCs were cultured in a 300 μl drop for 24 h, treatment
(2), 30 COCs were co-cultured from 0 to 24 h with 150 DOs in a 300 μl drop,
after which the 30 complexes were removed and fertilized (Fig. 1). Treatment 2
yields a ratio of 1 COC to 5 DOs in a 10 μl drop, giving a concentration of 0.5
DO/μl which is within the range required to examine the influence of OSFs
(Gilchrist et al., in press; Hussein et al., 2005). After IVM, all complexes were
fertilized and the number and quality of blastocyst formationwas assessed on day
8. Six replicate experiments were performed.
Experiment 2: effect of BMP15 and/or GDF9 during IVM on oocyte
developmental competence
This experiment was conducted to determine if addition of exogenous
recombinant OSFs, GDF9 and/or BMP15, during IVM improves subsequent
oocyte developmental competence. COCs were cultured for 24 h in the base
IVMmedium described above, with the following additional treatments (1) none
(control), (2) 175 ng/ml GDF9, (3) 10% v/v BMP15, (4) 10% v/v BMP15 and
175 ng/ml GDF-9 and (5) 10% v/v 293H. After IVM, all complexes were
fertilized and blastocyst formation was assessed on day 8. Four replicates of
these experiments were performed using 50 COCs per treatment group per
replicate experiment.
Experiments 3 and 4: effect of GDF9 or BMP15 antagonists on oocyte
developmental competence
The aim of this experiment was two-fold: (1) to examine the effect of
inhibiting the GDF9 or BMP15 secreted by the oocyte within an intact COC onsubsequent development and (2) to specifically neutralize the effects of the
recombinant OSFs on COCs as these preparations are not pure. COCs were
either cultured alone, with 175 ng/ml GDF9 or 10% v/v 293H, either in the
presence or absence of 4 μM SB-431542 (GDF9 antagonist). In a separate
experiment, COCs were cultured alone, or with 10% v/v BMP15 or 10% v/v
293H, either in the presence or absence of 10 μg/ml of follistatin-288 during
IVM. After IVM, all complexes were fertilized and blastocyst formation was
assessed on day 8. Three replicates of these experiments were performed using
60 COCs per treatment group per replicate experiment.
Statistical analyses
All replicated proportional development data were arc-sine transformed
prior to analysis. Statistical analyses were carried out by ANOVA using
SigmaStat software (SPSS Inc, Chicago, IL), and significant differences
between means were determined using Tukey–Kramer post hoc test for
comparison of multiple means. Differences were considered statistically
significant at P<0.05.Results
Experiment 1: effect of co-culture of intact COCs with DOs
during IVM on subsequent developmental competence
Exposure of intact COCs to native OSFs from DOs
significantly increased (P<0.001) the proportion of oocytes
Table 1A








COC 182 83.0±0.9 38.8±0.9a
COC+DOs 176 82.5±0.7 51.0±0.9b
a,b Values with different superscripts within the same column represent a
statistically significant difference (P<0.001). Values are expressed as
(mean±SEM).
Table 2








Control 205 86.5±3.2 41.0±0.9a,c
GDF9 191 88.1±2.0 49.5±3.9a,b
BMP15 189 88.7±4.2 57.5±2.4b
GDF9+BMP15 184 88.9±2.9 55.1±4.5b
293H 187 80.4±2.2 27.1±3.1c
a–c Values with no common superscripts within the same column are
significantly different (P<0.05). Values are expressed as (mean±SEM).
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compared with COCs cultured alone (39%) (Table 1A).
Furthermore, the cell numbers of the ensuing blastocysts were
significantly (P<0.05) increased, with more total and
trophectoderm cell numbers, compared to control COCs
(Table 1B). However, cleavage of oocytes was not signifi-
cantly affected by exposure to OSFs during IVM (P>0.05;
Table 1A).
Experiment 2: effect of BMP15 and/or GDF9 during IVM on
oocyte developmental competence
Addition of BMP15 to maturing COCs dramatically
enhanced (P<0.05) their development to the blastocyst stage,
by 16% compared to control COCs or 30% compared to 293H-
treated COCs (Table 2). Conditioned medium from the parent
293H cell line adversely affected oocyte developmental
potential, lowering blastocyst rates by 14% compared to control
COCs (P<0.001). GDF9 also increased (P<0.05) blastocyst
yield compared to 293H-treated COCs, but not compared to
COCs cultured alone. There was no additive effect on blastocyst
yield of GDF9 above that of BMP15 alone. Cleavage of oocytes
was not significantly affected by the treatment groups, although
rates were notably lower in those exposed to the 293H control
conditioned medium.
Experiments 3 and 4: effect of GDF9 or BMP15 antagonists on
oocyte developmental competence
The adverse effect of adding 293H during IVM on cleavage
rate observed in the previous experiment 2 was also observed
in both of these experiments; the difference from control
groups was now significant (2-way ANOVA, P<0.05; Figs.
2A and 3A). The GDF9 antagonist SB-431542, which is an
ALK 4/5/7 inhibitor, had no influence of the cleavage rate of
the oocyte (P>0.05; Fig. 2A). In contrast, treatment of COCs
with follistatin, regardless of BMP15 treatment, significantlyTable 1B





COC 40 148.3±1.2a 50.0±1
COC+DOs 51 156.1±1.3b 49.4±1
a,b Values with different superscripts within the same column represent a statisticallydecreased cleavage rate of oocytes (follistatin, 71.8±1.3;
control, 76.2±1.3; P=0.007; Fig 3A). Consistent with
experiment 2, treatment of COCs with GDF9 did not
significantly alter cleavage rates compared to the control, nor
did treatment with BMP15, independent of any effects of
follistatin (Figs. 2A and 3A).
Treatment of control COCs with SB-431542 or follistatin
significantly (P<0.05) decreased blastocyst development,
compared to untreated COCs, suggesting that these antago-
nists were able to at least partially neutralize the effect of
endogenous GDF9 or BMP15, respectively, that was secreted
by the oocyte (Figs. 2B and 3B). Consistent with experiment
2, exogenous GDF9 and BMP15 both increased blastocyst
yields (P<0.05) in these experiments (Figs. 2A and 3A), and
these increases were ablated by the addition of their
respective antagonists. Addition of SB-431542 or follistatin
not only reduced blastocyst development to levels similar to
untreated control COCs but further depressed blastocyst rates
to the levels of the control COCs treated with antagonists
(Figs. 2B and 3B). This suggests that SB-431542 and
follistatin are neutralizing the effects of both exogenous and
endogenous GDF9 or BMP15 on developmental competence
of the oocyte. Blastocyst development rates from COCs
matured with 293H were substantially reduced (P<0.05),
regardless of whether SB-431542 or follistatin was added
(Figs. 2B and 3B).
Discussion
For at least three decades, it has been known that the oocyte
is dependent on granulosa cells and CCs to provide nutrients
and regulatory signals through gap junctions (Anderson and
Albertini, 1976; Buccione et al., 1990a). More recently, a
growing body of evidence has shown that paracrine factors
secreted from the oocyte potently regulate follicular somaticpanded and hatched blastocysts following co-culture of COCs with DOs
TE
ells Proportion Mean cells Proportion
.3a 33.6±0.6a 98.2±0.8a 66.4±0.6a
.1a 31.5±0.5b 105.7±1.3b 68.5±0.5a
significant difference (P<0.05).
Fig. 2. Effect of treatment of intact COCs with GDF9 in the presence or absence
of the GDF9 antagonist SB-431542, during IVM on subsequent cleavage (A)
and developmental competence (B). Following IVM, all complexes were
fertilized, and the cleavage rate was assessed on day 2 and blastocyst formation
on day 8. 293H is control-conditioned medium from untransfected 293H cells.
Bars represent percentages (mean±SEM), and bars or grouped bars within a
graph with different labels a–d differ significantly (P<0.05). Cleavage rate was
not affected by SB-431542 but was by 293H.
Fig. 3. Effect of treatment of intact COCs with BMP15 in the presence or
absence of follistatin during IVM on subsequent cleavage (A) and develop-
mental competence (B). After IVM, all complexes were fertilized, cleavage rate
was assessed on day 2 and blastocyst formation on day 8. 293H is control-
conditioned medium from untransfected 293H cells. Bars represent percentages
(mean±SEM), and bars or grouped bars within a graph with different labels a–d
differ significantly (P<0.05). Cleavage rate was adversely affected by follistatin
and by 293H.
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entiation, apoptosis and expansion (Eppig, 2001; Gilchrist et
al., 2004a; Hussein et al., 2005). We now provide evidence
that oocyte-secreted factors enhance oocyte developmental
competence during in vitro maturation, whether in their native
form as an uncharacterized mix of growth factors secreted by
the oocyte, or as recombinant exogenous BMP15 and GDF9
(Fig. 4). Our data demonstrate that not only do OSFs regulate
development of their neighboring somatic cells, but also in
doing so, the oocyte, through the secretion of paracrine signals
within the COC, contributes to the very processes of oocyte
maturation and the acquisition of its own developmental
competence during in vitro maturation.
The capacity of an oocyte to support fertilization and
preimplantation embryo development, termed oocyte develop-
mental competence, is acquired during folliculogenesis. While
oocyte meiotic competence is acquired during early folliculo-
genesis, developmental competence is acquired first during the
antral phase as the oocyte approaches ovulation (Eppig et al.,
1994). During this latter phase of development, the oocytemaintains intimate contact with, and is reliant on, its CCs and is
relatively isolated from the rest of the follicle. The COC
provides a highly specialized microenvironment, and the CCs
are functionally distinct from the remaining granulosa cells in
the follicle features that are dependent on paracrine signals from
the oocyte (Eppig et al., 1997; Li et al., 2000). We have
previously hypothesized that the process of maintenance of the
specialized COC microenvironment by OSFs may be required
for appropriate programming of the oocyte cytoplasm to support
early development (Gilchrist et al., 2004a). The findings from
the current study provide strong support for this hypothesis,
especially during in vitro maturation, where the culture
conditions are most likely to be sub-optimal for CC function
in comparison to the follicular environment. Hence, the
capability of individual oocytes to secrete paracrine factors,
presumably to appropriately direct CC functions, appears to be a
determinant of oocyte developmental competence.
It is not yet clear which particular functions of CCs regulated
by OSFs impart developmental competence on the oocyte, even
though it is now widely accepted that the characteristic
Fig. 4. Diagrammatic illustration of the hypothetical model derived from this
study. Exposure of COCs during oocyte maturation to oocyte-secreted factors
(OSFs), whether in their native form as an uncharacterized mix of growth factors
secreted by the oocyte or as exogenous recombinant BMP15 or GDF9,
substantially improves subsequent oocyte developmental competence (from
∼40% to ∼60%). OSFs are known to regulate a multitude of cumulus cell
functions, and this model proposes that these may include positive regulatory
factors that pass back to the oocyte (bold arrows), improving subsequent
development.
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et al., 2004a). Diffusible paracrine factors produced by oocytes
promote the expression of an array of CC genes and regulate a
broad range of CC functions. For example, CC gene expression
of hyaluronic acid synthase 2 (HAS2), cyclooxygenase 2
(COX2; PTGS2) and gremlin (GREM1), which are regulated by
GDF9 (Elvin et al., 1999; Pangas et al., 2004), have been
correlated to developmental competence of human oocytes
(McKenzie et al., 2004). Mucification and expansion of CCs are
essential for ovulation, sperm capacitation and fertilization
(Tanghe et al., 2003), and this feature of CCs that distinguishes
them from mural granulosa cells is under OSF control
(Buccione et al., 1990b; Dragovic et al., 2005). Furthermore,
the incidence of CC apoptosis has been proposed as a useful
predictor of subsequent embryo developmental outcomes (Host
et al., 2002; Ikeda et al., 2003; Lee et al., 2001). These CC
processes are regulated by oocyte-derived paracrine factors
(Dragovic et al., 2005; Elvin et al., 1999; Eppig, 2001; Hussein
et al., 2005; Pangas et al., 2004). Recently, it has been
demonstrated that glycolysis and amino acid uptake in CCs and
transfer of these substrates to the oocyte are regulated by OSFs
(Eppig et al., 2005; Sugiura and Eppig, 2005). Thus, the oocyte
is dependent on CCs for the supply of many small regulatory
molecules, such as cAMP, and energy substrates, in particular
pyruvate, such that CCs nurture the oocyte towards develop-
mental competence (Sutton et al., 2003). This may be an
important mechanism by which OSFs improve oocyte devel-
opmental competence.
The present study demonstrates that treating intact COCs
with OSFs during IVM substantially increases the proportion of
oocytes reaching the blastocyst stage of development. In a
bovine serum-free model, the blastocyst rate from IVM of amixed pool of oocytes collected from 3 mm to 8 mm follicles is
generally limited to about 30–40% (Rizos et al., 2002). In the
current study, a blastocyst rate of ∼60% was achieved using
serum-free defined medium, simply by the addition of naturally
occurring OSFs, which is a substantial increase to levels similar
to that achieved using in vivo matured oocyte (Rizos et al.,
2002). Nevertheless, we have yet to determine if oocytes from
any particular subclass of follicles are particularly affected by
the addition of OSFs.
In addition to increasing blastocyst yield, exposure of
COCs to OSFs also altered the characteristics of resulting
blastocysts by increasing the total cell numbers. Increased
total cell numbers in mouse embryos are associated with
improved embryo quality and post-implantation developmen-
tal potential (Lane and Gardner, 1997). In the current study,
the observed increase in total cell numbers was attributed to
an increase in trophectoderm cell numbers, with no change to
the ICM. Although improved levels of post-implantation
development are associated with increased ICM cells numbers
rather than trophectoderm cell numbers in the mouse (Lane
and Gardner, 1997), little is known of the impact of such
alterations in bovine embryos. When Koo et al. (2002)
compared the total, trophectoderm and ICM cell numbers of in
vivo to in vitro derived blastocysts and to blastocysts derived
from somatic cell nuclear transfer, the ICM cell number did
not vary significantly (approximately 42–49 cells for each
type of blastocyst). In contrast, trophectoderm cell numbers
varied from a mean of 80.5 for in vivo blastocysts (highest
developmental potential) to 62.4 cells for in vitro derived
blastocysts and 49.5 cells for nuclear transfer blastocysts
(lowest developmental potential). Hence, while the increased
total and trophectoderm cell numbers of blastocysts derived
from COCs exposed to OSFs could reflect improved embryo
quality, embryo transfer experiments are required to verify
this.
Since the beneficial effects of denuded oocytes on oocyte
developmental competence were observed in a co-culture
system that does not require physical contact between the
cells, the active substances are most likely soluble paracrine
signals secreted by the oocyte acting on CCs. Furthermore,
the improvement was achieved with OSFs either in a native
form as an uncharacterized mix of growth factors secreted
from the oocyte or as a recombinant GDF9 or BMP15.
Recent important studies have demonstrated the critical
involvement of GDF9 and BMP15 in the regulation of
fertility through their roles in regulating early follicle growth
and ovulation rate (reviewed in McNatty et al., 2004).
Moreover, the current study shows that GDF9 and BMP15
play an important role in regulating oocyte developmental
programming and shed new light on the importance of
oocyte–CC interactions during the final stages of oocyte
development (Fig. 4).
It is interesting to note that both BMP15 and GDF9
increased oocyte developmental competence independently,
despite the fact that they elicit different intracellular responses
(Shimasaki et al., 2004). This suggests that both the SMAD
1/5/8 pathway (activated by BMP15) and the SMAD2/3
520 T.S. Hussein et al. / Developmental Biology 296 (2006) 514–521pathway (activated by GDF9) in CCs are in someway
involved in regulating developmental competence of the
oocyte. We recently demonstrated that OSFs prevent CC
apoptosis and that this is mediated by BMP, not GDF9,
signaling (Hussein et al., 2005). As both GDF9 and BMP15
are required for fertility in sheep (McNatty et al., 2004),
bovine oocytes probably activate both TGF-β superfamily
signaling pathways in CCs, in contrast to mice, where murine
oocytes predominately activate SMAD2/3 (Gilchrist et al., in
press), consistent with BMP15 playing a less critical role in
this species (Yan et al., 2001). BMP15 and GDF9 are also
known to interact synergistically to regulate some granulosa
cell functions (McNatty et al., 2005a,b), although in the
current study, combined treatment with BMP15 and GDF9
did not further increase developmental competence of oocytes
beyond that of BMP15 alone. However, this may be due to a
doubling of the intrinsic inhibitory factors produced by the
parent cell line present in the 293H conditioned media. These
growth factors are prepared in a partially purified form
(Hickey et al., 2005), and it is noteworthy that conditioned
medium from untransfected 293H cells had a marked
inhibitory effect on oocyte developmental competence,
suggesting that purified GDF9 and/or BMP15 may even
further enhance oocyte quality.
Due to the impurity of GDF9 and BMP15 preparations used
in this study, a further objective was to confirm that the
improvement in oocyte developmental competence was due
specifically to GDF9 or BMP15. This was achieved in GDF9
and BMP15 neutralization experiments. Follistatin is an activin
and BMP15 binding protein and neutralizes their bioactivities
(Hussein et al., 2005; Otsuka et al., 2001). SB-431542 is a
kinase inhibitor that antagonizes the biological activities of
TGF-β1, activin and GDF9, but has no effect on the BMPs
(Gilchrist et al., in press; Inman et al., 2002). SB-431542 and
follistatin ablated the positive effects of exogenous GDF9 and
BMP15, respectively, on oocyte developmental competence.
Interestingly, when added to untreated COCs, these antagonists
also decreased oocyte developmental potential, possibly by
antagonizing the positive effects of endogenous GDF9 and
BMP15 in the intact COC. This is consistent with a previous
study where addition of follistatin had an adverse effect on
blastocyst yield (Silva and Knight, 1998) and provides further
evidence that oocyte secretion of BMP15 enhances the
developmental program of the oocyte.
Collectively, the evidence presented in this study demon-
strates, for the first time, that oocytes, in particular the oocyte-
secreted factors BMP15 and GDF9, enhance oocyte develop-
mental competence during in vitro maturation by their known
effects on CC function. These results have significant implica-
tions for improving the efficiency of oocyte maturation tech-
nologies and support the role of OSF production by oocytes as a
diagnostic marker for developmental competence.
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